Clinical Study of Ligustrazine Magnetic Nanoparticles Combined with Moxibustion in the Treatment of Migraine

Abstract

The purpose of this article is to explore the clinical application of ligustrazine magnetic nanoparticles combined with moxibustion in the treatment of migraine. In this study 60 patients diagnosed with migraine were enrolled and divided into three groups of ligustrazine magnetic nanoparticles group, moxibustion treatment group and ligustrazine magnetic nanoparticles combined moxibustion group. Patients in ligustrazine magnetic nanoparticles treatment group were injected with quantitative ligustrazine magnetic nanoparticles, moxibustion treatment group used self-adhesive small. Acupuncture moxibustion in patients with moxibustion patients, ligustrazine magnetic nanoparticles combined with moxibustion treatment group using the combination of the above two treatments, after the treatment period, the treatment of patients in each group is effective, prognosis recurrence rate and adverse reaction rate perform statistics and analysis. The research results show that the treatment efficiency of the ligustrazine magnetic nanoparticles combined with moxibustion treatment group is as high as 97.2%, which is higher than that of the other two groups. The prognosis recurrence rate is only 4.76%, which is lower than that of the other two groups, and the adverse reaction rate is 3.85%, which is lower than the other two groups. It can be seen that the treatment of ligustrazine magnetic nanoparticles combined with moxibustion is an effective way to treat migraine.